Trends in Hepatocellular Carcinoma among Hepatitis C Patients Achieving Sustained Virological Response Following Direct-Acting Antivirals Treatment

Trends in Hepatocellular Carcinoma among Hepatitis C Patients Achieving Sustained Virological Response Following Direct-Acting Antivirals Treatment

-

Saved in:

Bibliographic Details
Main Author:	Ummi Maimunah
Format:	Article
Language:	English
Published:	Interna Publishing 2024-12-01
Series:	The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Online Access:	https://ina-jghe.com/index.php/jghe/article/view/1056
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Incidence and Factors of Hepatocellular Carcinoma in Hepatitis C Virus Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Treatment
by: Juferdy Kurniawan Kurniawan, et al.
Published: (2024-12-01)

Sorafenib-treated hepatocellular carcinoma with or without prior direct-acting antiviral therapy for hepatitis C: outcomes and survival
by: Rania Lithy, et al.
Published: (2025-08-01)

Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study
by: Shou-Wu Lee, et al.
Published: (2025-07-01)

Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis
by: Kurinchi Selvan Gurusamy, et al.
Published: (2025-07-01)

Persistence of hepatitis C virus in peripheral blood mononuclear cells of patients who achieved sustained virological response following treatment with direct-acting antivirals is associated with a distinct pre-existing immune exhaustion status
by: Sylwia Osuch, et al.
Published: (2025-06-01)

Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?
by: Carlo Smirne, et al.
Published: (2024-12-01)

Hepatocellular carcinoma surveillance after sustained virological response in chronic hepatitis C: Editorial on “Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-analysis”
by: Ho Soo Chun, et al.
Published: (2025-01-01)

Primary hepatic large B-cell lymphoma following direct-acting antiviral treatment for hepatitis C
by: Yosra Zaimi, et al.
Published: (2021-10-01)

Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinoma
by: Yuko Nagaoki, et al.
Published: (2025-03-01)

Development of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C 21 Years after Achieving a Sustained Virological Response to Interferon Therapy
by: Tasuku Hara, et al.
Published: (2020-01-01)

Comment: Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus
by: Xinpu Miao, et al.
Published: (2025-01-01)

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
by: Eric R. Yoo, et al.
Published: (2016-01-01)

Long-term results of antiviral therapy in patients with chronic hepatitis C with sustained virologic response
by: T. M. Ignatova, et al.
Published: (2013-09-01)

Effect of Low Positive End of Treatment Viral Load with Direct-Acting Antiviral Therapy on Sustained Virologic Response
by: Vabhave Pal, et al.
Published: (2020-01-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)

Self-reported experience in patients treated with Hepatitis C direct acting antivirals
by: Irene Cañamares Orbis, et al.
Published: (2016-12-01)

Medicaid and Medicare Utilization of Direct-Acting Antiviral Medications for Patients With Hepatitis C
by: Xiaohan Ying, et al.
Published: (2025-01-01)

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
by: Peter Karayiannis
Published: (2012-01-01)

Effects of Various Direct-acting Antivirals in the Quality of Life of Patients with Chronic Hepatitis C
by: Hatun ÖZTÜRK ÇERİK, et al.
Published: (2021-12-01)

Treatment of the chronic hepatitis C complicated by mixed cryoglobulinemia with direct-acting antiviral agents
by: N. V. Dunaeva, et al.
Published: (2018-12-01)

The effect of cognitive emotion regulation on direct-acting antivirals adherence in patients with hepatitis C
by: Adina Turcu-Stiolica, et al.
Published: (2024-11-01)

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.
by: Fei Xiao, et al.
Published: (2014-05-01)

Analysis of high-risk factors for hepatocellular carcinoma after sustained virological suppression of chronic hepatitis B
by: Jianna Zhang, et al.
Published: (2025-04-01)

Changes in liver stiffness measurements following hepatitis C sustained virologic response among Alaska Native adults treated with sofosbuvir-based direct acting anti-viral therapy
by: Janet M. Johnston, et al.
Published: (2025-12-01)

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.
by: Rakesh Aggarwal, et al.
Published: (2017-01-01)

Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment
by: Sona Sargsyan, et al.
Published: (2024-05-01)

Efficacy of direct-acting antivirals in patients with hepatitis C virus-associated cryoglobulinemic vasculitis: Results of a long-term follow-up
by: S. V. Gavrisheva, et al.
Published: (2023-04-01)

Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
by: Tom Ryu, et al.
Published: (2025-04-01)

Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection
by: Paolo Carta, et al.
Published: (2020-05-01)

Treatment of hepatitis C using direct-acting antiviral (DAA) agents in patients undergoing liver transplantation
by: V. E. Syutkin, et al.
Published: (2016-02-01)

Direct-Acting-Antivirals Anti-hepatitis C Virus in Renal Transplant Patients: Relevance of Pharmacologic Interaction
by: Maurizio Salvadori, et al.
Published: (2020-08-01)

Are there differences in efficacy and safety between local and imported direct-acting antiviral agents for hepatitis C in China?
by: Zhitao Wang, et al.
Published: (2025-07-01)

Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era.
by: Autumn Zuckerman, et al.
Published: (2018-01-01)

Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics
by: Hossain M.S. Sazzad, et al.
Published: (2025-05-01)

Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus
by: Pradeep Kumar Mada, et al.
Published: (2020-01-01)

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs)
by: Lorenza Di Marco, et al.
Published: (2025-01-01)

Markedly Improved Glycemic Control in Poorly Controlled Type 2 Diabetes following Direct Acting Antiviral Treatment of Genotype 1 Hepatitis C
by: Raymond Anthony Pashun, et al.
Published: (2016-01-01)

Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease
by: Mahmoud Saif-Al-Islam, et al.
Published: (2021-01-01)

Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.
by: Meritxell Llorens-Revull, et al.
Published: (2021-01-01)

Success of a second treatment of direct-acting antiviral therapy in patients with chronic Hepatitis C Virus infection.
by: Daniela L. Andrade-González, et al.
Published: (2025-04-01)